Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Concurrent Chemoradiation Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00174772
What this trial is testing

Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Neoplasms
Sanofi 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07365280
What this trial is testing

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
ZSky Biotech Inc 78
Large-scale testing (Phase 3)Looking for participantsNCT06926543
What this trial is testing

Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy

Who this might be right for
Invasive Breast CancerStage III Breast CancerStage IIB Breast Cancer
Dr. Tabassum Wadasadawala 858
Testing effectiveness (Phase 2)UnknownNCT04514835
What this trial is testing

A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 44
Post-approval studies (Phase 4)Study completedNCT03998696
What this trial is testing

An Experimental Study to Compare Treatment Response and Toxicities of Concurrent Chemoradiation With Weekly Cisplatin and Three Weekly Cisplatin in Locally Advanced Head and Neck Cancer.

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06992609
What this trial is testing

Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.

Who this might be right for
Small Cell Lung Carcinoma
AstraZeneca 68
Testing effectiveness (Phase 2)UnknownNCT03469531
What this trial is testing

Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Who this might be right for
NeoplasmsCervical Adenosquamous Cell CarcinomaCervical Squamous Cell Carcinoma in Situ+5 more
Zhujiang Hospital 100
Post-approval studies (Phase 4)UnknownNCT00642239
What this trial is testing

A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma

Who this might be right for
Esophageal Carcinoma
Shandong Luye Pharmaceutical Co., Ltd. 48
Not applicableLooking for participantsNCT07801235
What this trial is testing

HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC)

Who this might be right for
Head and Neck (HNSCC)
King Hussein Cancer Center 604
Testing effectiveness (Phase 2)Looking for participantsNCT05758389
What this trial is testing

Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors

Who this might be right for
Head and Neck Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 29
Not applicableLooking for participantsNCT04680377
What this trial is testing

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients

Who this might be right for
NSCLC, Stage IIILocally Advanced Lung Carcinoma
Jun Zhang, MD, PhD 44
Testing effectiveness (Phase 2)UnknownNCT06433830
What this trial is testing

Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy

Who this might be right for
ThrombocytopeniaRadiotherapy Side Effect
Sir Run Run Shaw Hospital 50
Early research (Phase 1)Ended earlyNCT02317302
What this trial is testing

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Who this might be right for
Cervical CancerUterine Cervical CancerUterine Cervical Neoplasms
Washington University School of Medicine 48
Large-scale testing (Phase 3)Ended earlyNCT01461772
What this trial is testing

Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Asan Medical Center 21
Testing effectiveness (Phase 2)UnknownNCT04801511
What this trial is testing

Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Zhou Fuxiang 60
Testing effectiveness (Phase 2)Study completedNCT04508816
What this trial is testing

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 45
Large-scale testing (Phase 3)Study completedNCT03600831
What this trial is testing

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Huai'an First People's Hospital 434
Testing effectiveness (Phase 2)Looking for participantsNCT06170710
What this trial is testing

Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 173
Testing effectiveness (Phase 2)UnknownNCT02268006
What this trial is testing

IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment

Who this might be right for
Rectal Carcinoma
Institute of Oncology Ljubljana 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04624204
What this trial is testing

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

Who this might be right for
Small Cell Lung Cancer
Merck Sharp & Dohme LLC 672
Next Page